![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Two Year Tenofovir Disoproxil Fumarate (TDF) Treatment and Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102)
|
|
|
Reported by Jules Levin
13th International Symposium on Viral Hepatitis and Liver Disease
March 20th-24th 2009
Washington DC
Patrick Marcellin1, Maria Buti2, Zahary Krastev3, Selim Gurel4, Rozalina Balabanska5, Geoff Dusheiko6, Robert Myers7, E Jenny Heathcote8, Jeff Sorbel9, Jane Anderson9, Elsa Mondou9 and Franck Rousseau9
1Hopital Beaujon, Clichy, France; 2Hospital Valle Hebron, Barcelona, Spain; 3University Hospital "St Ivan Rilsky", Sofia, Bulgaria; 4University of Uludag, Bursa, Turkey; 5Tokuda Hospital, Sofia, Bulgaria; 6Royal Free Hospital, London U.K.; 7University of Calgary, Calgary Alberta, Canada; 8Toronto Western Hospital, University of Toronto, Toronto Ontario, Canada; 9Gilead Sciences, Durham NC
![conclusion-1.gif](../images/032409/conclusion-1.gif)
![aim-2.gif](../images/032409/aim-2.gif)
![HB-3.gif](../images/032409/HB-3.gif)
![methods-4.gif](../images/032409/methods-4.gif)
![base-5.gif](../images/032409/base-5.gif)
![CI-6.gif](../images/032409/CI-6.gif)
![rapd-7.gif](../images/032409/rapd-7.gif)
![genoe-8.gif](../images/032409/genoe-8.gif)
![Open-9.gif](../images/032409/Open-9.gif)
![Ranndom-10.gif](../images/032409/Ranndom-10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|